In addition, a significant increase in gene expression of the Nrf2 target gene NAD(P)H quinone dehydrogenase 1 (NQO1) was reported in monocytes from patients with CKD without renal replacement therapy [32]. This evidence concerns the gene NFE2L2 and chronic kidney disease.